Overview

Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The trial is to investigate the safety and efficacy of oral lithium, intraspinal umbilical cord blood mononuclear cell transplant, and the combination in the treatment of acute and subacute spinal cord injury
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
China Spinal Cord Injury Network
Collaborators:
Chengdu PLA General Hospital
StemCyte, Inc.
Treatments:
Lithium Carbonate